SAVIMS

Analysis of Graphene Oxide in COVID-19 Vaccines

Reference:

Young, R. O. (2021, February 5; updated September 11). Scanning & transmission electron microscopy reveals graphene oxide in CoV-19 vaccines. Retrieved from www.drrobertyoung.com

Summary:

In his article, Robert O. Young presents findings from a study using various microscopy techniques to investigate the presence of graphene oxide in COVID-19 vaccines from Pfizer, Moderna, AstraZeneca, and Janssen. The research highlights that these vaccines may contain undisclosed ingredients, specifically reduced graphene oxide (rGO) particles, which could potentially pose health risks. Young argues that the lack of transparency regarding vaccine ingredients violates human rights, particularly under the Nuremberg Code. The study employed methods such as phase contrast microscopy and energy-dispersive spectroscopy to identify and compare the vaccine contents, revealing the presence of rGO and other nanoparticles. Young emphasises the need for complete disclosure of vaccine ingredients to enable informed consent from individuals receiving vaccinations. He raises concerns about the implications of undisclosed materials, linking them to potential adverse health effects and questioning the classification of these vaccines as mere immunisations rather than advanced nanotechnological therapies.

DOWNLOAD

Scroll to Top